Press Releases Novonesis A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:30 2024-05-01 am EDT			5-day change	1st Jan Change
383.6 ^DKK	-1.29%		-1.26%	+3.37%

Apr. 30	Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	CI
Apr. 08	Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	CI

Novonesis A/S : Resolutions from the annual shareholders' meeting 2024	Apr. 30	PU
Resolutions from the annual shareholders’ meeting 2024	Apr. 30	GL
Novonesis A/S : Invitation to the annual shareholders' meeting	Apr. 08	PU
Invitation to the annual shareholders’ meeting	Apr. 08	GL
Share-based legacy RSU program granted	Apr. 08	GL
2024 outlook and pro forma financials	Mar. 21	GL
2024 outlook and pro forma financials	Mar. 21	AQ
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21	Mar. 18	GL
Novonesis A/S : Resolutions from the Extraordinary Shareholders' Meeting 2024	Mar. 04	PU
Resolutions from the Extraordinary Shareholders’ Meeting 2024	Mar. 04	GL
Invitation to an extraordinary shareholders’ meeting of Novozymes A/S	Feb. 09	GL
The Novozymes Report 2023	Feb. 08	GL
Trading by management and close relations of management	Feb. 02	GL
Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed	Feb. 02	GL
Legacy Novozymes delivers solid last full-year results	Feb. 01	GL
Results update for 2023 – unaudited	Feb. 01	GL
Legacy Novozymes delivers solid last full-year results	Feb. 01	AQ
Results update for 2023 – unaudited	Feb. 01	AQ
Trading by management and close relations of management	Jan. 29	GL
Major shareholder announcement	Jan. 29	GL

No results for this search

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 09:18 am EST